Systemic Chemotherapy with Combination of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor in Unresectable Hepatocellular Carcinoma

被引：0
|
作者：
Chon, Hye Yeon [1 ,2 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yongin Severance Hosp, Dept Internal Med, 363 Dongbaekjukjeon Daero, Yongin 16995, South Korea
来源：
KOREAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 83卷 / 02期
关键词：
ATEZOLIZUMAB;
D O I：
10.4166/kjg.2024.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [21] Efficacy and safety of triple combination therapy with transarterial chemoembolization (TACE), tyrosine kinase inhibitor (TKI), and immune checkpoint inhibitor (ICI) versus dual combination therapy in unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis
    Maano, O. P.
    Malbas, J. M. V.
    Dy, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S614 - S614
  • [22] Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
    Lee, Pei-Chang
    Chao, Yee
    Chen, Ming-Huang
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [23] Present and prospect of transarterial chemoembolization combined with tyrosine kinase inhibitor and PD-1 inhibitor for unresectable hepatocellular carcinoma
    Zhang, Rui
    Liu, Yan-Hui
    Li, Yu
    Li, Nan-Nan
    Li, Zheng
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (11)
  • [24] Determinants of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor therapy response in renal cell carcinoma
    Gu, L.
    Liang, Q.
    Zhang, X.
    Wang, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1507 - S1507
  • [25] Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy
    Amioka, Kei
    Kawaoka, Tomokazu
    Ogawa, Yutaro
    Kikukawa, Chihiro
    Naruto, Kensuke
    Yoshikawa, Yuki
    Ando, Yuwa
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Fukuhara, Takayuki
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Masaki, Keiichi
    Honda, Yoji
    Kouno, Hirotaka
    Kohno, Hiroshi
    Chayama, Kazuaki
    Aikata, Hiroshi
    ONCOLOGY, 2021, 99 (05) : 327 - 335
  • [26] PROGNOSTIC IMPACT OF TYROSINE KINASE INHIBITOR SEQUENTIAL TREATMENT INCLUDING LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Otsuka, Kanako
    Shibata, Hiroshi
    Kumada, Takashi
    Hiraoka, Atsushi
    Atsukawa, Masanori
    Hirooka, Masashi
    Tsuji, Kunihiko
    Ishikawa, Toru
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Tanaka, Hironori
    Tamai, Tsutomu
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    GASTROENTEROLOGY, 2020, 158 (06) : S1144 - S1144
  • [27] Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
    Han, Feng
    Wang, Xiao-Han
    Xu, Chen-Zhou
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (07)
  • [28] TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
    Reiter, Florian P.
    Geier, Andreas
    LANCET, 2025, 405 (10474): : 174 - 176
  • [29] Fibrillary Glomerulonephritis in a Patient on Dual Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Therapy
    Chewcharat, Api
    Chowdhury, Raad Bin Zakir
    Petrosyan, Romela
    Shah, Sujal I.
    Gupta, Shruti
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [30] Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
    Gigante, Elia
    Hobeika, Christian
    Le Bail, Brigitte
    Paradis, Valerie
    Tougeron, David
    Lequoy, Marie
    Bouattour, Mohamed
    Blanc, Jean-Frederic
    Ganne-Carrie, Nathalie
    Tran, Henri
    Hollande, Clemence
    Allaire, Manon
    Amaddeo, Giuliana
    Regnault, Helene
    Vigneron, Paul
    Ronot, Maxime
    Elkrief, Laure
    Verset, Gontran
    Trepo, Eric
    Zaanan, Aziz
    Ziol, Marianne
    Ningarhari, Massih
    Calderaro, Julien
    Edeline, Julien
    Nault, Jean-Charles
    LIVER CANCER, 2022, 11 (05) : 460 - 473
12345